Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Intarcia Snags $210M to Push Implantable Device for Diabetes 11/15/12 Boston
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More 04/27/12 San Diego
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More 03/08/12 San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Unlimited Abilities: A View from the MedtechVision Conference 09/27/11 San Francisco
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News 08/12/11 Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Bydureon FDA Deadline Set 08/10/11 San Diego
Amylin & Takeda Halt Obesity Drug Development 08/04/11 San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News 08/04/11 San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Bydureon Sent Back to FDA 07/28/11 San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News 07/28/11 San Diego
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA 07/07/11 San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech” 07/06/11 Boston
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News 06/30/11 San Diego
A San Diego Sampler from the War on Diabetes 06/24/11 San Diego
Inception 1 Raises $5M, VCs Pessimistic About U.S. Biotech Funding, EU Approves Amylin’s Once-a-Week Diabetes Drug, & More San Diego Life Sciences News 06/23/11 San Diego
Amylin, Alkermes Diabetes Med OKd in EU 06/21/11 San Diego
Page 1 of 6 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.